Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LDE225 in Combination With Paclitaxel in Patients With Advanced Solid Tumors - A Multicenter Phase I Trial

NCT01954355 is registered in ClinicalTrials.gov with Swiss Cancer Institute as lead sponsor.

NCT NCT01954355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01954355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LDE225 in Combination With Paclitaxel in Patients With Advanced Solid Tumors - A Multicenter Phase I Trial
Lead sponsor
Swiss Cancer Institute
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2013
Completion date
November 30, 2016
Enrollment
30 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer, solid tumor